(S)-3-(4-(Benzyloxy)phenyl)-2-(2-(1-(3-phenylpropanoyl)piperidin-4-yl)acetamido)propan-oic acid

ID: ALA4474533

Chembl Id: CHEMBL4474533

PubChem CID: 134349100

Max Phase: Preclinical

Molecular Formula: C32H36N2O5

Molecular Weight: 528.65

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CC1CCN(C(=O)CCc2ccccc2)CC1)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O

Standard InChI:  InChI=1S/C32H36N2O5/c35-30(22-26-17-19-34(20-18-26)31(36)16-13-24-7-3-1-4-8-24)33-29(32(37)38)21-25-11-14-28(15-12-25)39-23-27-9-5-2-6-10-27/h1-12,14-15,26,29H,13,16-23H2,(H,33,35)(H,37,38)/t29-/m0/s1

Standard InChI Key:  DQOARLAMFQDQNF-LJAQVGFWSA-N

Alternative Forms

  1. Parent:

    ALA4474533

    ---

Associated Targets(Human)

NCI-H1703 (410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1650 (1118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YAP1 Tchem Transcriptional coactivator YAP1 (194 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-9 (1037 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC827 (1172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H146 (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.65Molecular Weight (Monoisotopic): 528.2624AlogP: 4.64#Rotatable Bonds: 12
Polar Surface Area: 95.94Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.81CX Basic pKa: CX LogP: 4.64CX LogD: 1.39
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.36Np Likeness Score: -0.59

References

1.  (2018)  Yap1 inhibitors that target the interaction of yap1 with oct4, 

Source